APA (7th ed.) Citation

JD, S., NA, S., RA, F., P, H., R, K., L, P., . . . MS, R. (2023). Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder. Translational psychiatry, 13(1), 276. https://doi.org/10.1038/s41398-023-02579-z

Chicago Style (17th ed.) Citation

JD, Santoro, et al. "Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder." Translational Psychiatry 13, no. 1 (2023): 276. https://doi.org/10.1038/s41398-023-02579-z.

MLA (9th ed.) Citation

JD, Santoro, et al. "Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder." Translational Psychiatry, vol. 13, no. 1, 2023, p. 276, https://doi.org/10.1038/s41398-023-02579-z.